Liu Ting, Xu Shuanglan, Yang Jiao, Xing Xiqian
Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Yunnan University, 650021 Kunming, Yunnan, China.
Graduate School, Kunming Medical University, 650500 Kunming, Yunnan, China.
Rev Cardiovasc Med. 2024 Jun 17;25(6):217. doi: 10.31083/j.rcm2506217. eCollection 2024 Jun.
Pulmonary hypertension (PH) is a persistently progressive, incurable, multifactorial associated fatal pulmonary vascular disease characterized by pulmonary vascular remodeling. Long noncoding RNAs (lncRNAs) are involved in regulating pathological processes such as pulmonary vasoconstriction, thickening, remodeling, and inflammatory cell infiltration in PH by acting on different cell types. Because of their differential expression in PH patients, as demonstrated by the observation that some lncRNAs are significantly upregulated while others are significantly downregulated in PH patients, lncRNAs are potentially useful biomarkers for assessing disease progression and diagnosis or prognosis in PH patients. This article provides an overview of the different mechanisms by which lncRNAs are involved in the pathogenesis of PH.
肺动脉高压(PH)是一种持续进展、无法治愈、多因素相关的致命性肺血管疾病,其特征为肺血管重塑。长链非编码RNA(lncRNAs)通过作用于不同细胞类型,参与调节PH中的肺血管收缩、增厚、重塑和炎性细胞浸润等病理过程。由于在PH患者中观察到一些lncRNAs显著上调而另一些显著下调,表明它们在PH患者中存在差异表达,因此lncRNAs有可能作为评估疾病进展以及诊断或预测PH患者预后的生物标志物。本文概述了lncRNAs参与PH发病机制的不同机制。